About ATOMIC ALCHEMY
ATOMIC ALCHEMY is a company based in Idaho Falls (United States) founded in 2017 by Thomas Eiden was acquired by Oklo in February 2025. ATOMIC ALCHEMY has raised $150 thousand across 1 funding round from investors including Oklo and Y Combinator. ATOMIC ALCHEMY offers products and services including VIPR® Reactor and Fuel Recycling Process. ATOMIC ALCHEMY operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Niowave, Nanovista and Ground Fluor Pharmaceuticals, among others.
- Headquarter Idaho Falls, United States
- Founders Thomas Eiden
- SectorsHealthcare
- Website atomicalchemy.us
- Social LinkedIn Facebook
- Acquired by Oklo (Feb 2025)
- Legal Name Atomic Alchemy Inc
Products & Services of ATOMIC ALCHEMY
ATOMIC ALCHEMY offers a comprehensive portfolio of products and services, including VIPR® Reactor and Fuel Recycling Process.
Engineered reactor for producing high-value radioisotopes across various sectors.
Advanced method to retrieve isotopes from used nuclear fuel for applications.
Funding Insights of ATOMIC ALCHEMY
ATOMIC ALCHEMY has successfully raised a total of $150K through 1 strategic funding round. The most recent funding activity was a Seed round of $150 thousand completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $150,000
- Total Rounds 1
- Last Round Seed — $150,000
- First Round $150,000
(Jun 2019)
- Investors Count 1
All 1 funding rounds of ATOMIC ALCHEMY with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2019 | $150,000 | Seed | – | Y Combinator | – |
2 investors in total: 2 institutional.
Investors in ATOMIC ALCHEMY
ATOMIC ALCHEMY has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Oklo and Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated via funding and educational programs. | – | ycombinator.com | Mountain View, United States | |
Small modular reactors are developed for advanced nuclear energy solutions. | 2013 | oklo.com | Sunnyvale, United States |
Investor details for ATOMIC ALCHEMY
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ATOMIC ALCHEMY
1 people are tracked at ATOMIC ALCHEMY (1 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Eiden | Founder & CEO | Leadership |
Complete people profiles for ATOMIC ALCHEMY
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ATOMIC ALCHEMY
3 dated milestones of ATOMIC ALCHEMY across 8 years, from founding to its latest funding, stage changes and deals.
- Founded ATOMIC ALCHEMY is founded.
- Funding First funding round of $150K.
- Exit Acquired by Oklo.
Competitors of ATOMIC ALCHEMY
ATOMIC ALCHEMY operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Niowave, Nanovista and Ground Fluor Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| artms.ca | 2013 | Vancouver, Canada | $26.58M | – | Radioisotope technologies and services are developed and provided by ARTMS. | |
| northstarnm.com | 2006 | Madison, United States | $15.09M | – | Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market | |
| niowaveinc.com | 2006 | United States | $9.95M | – | Devices and radioisotopes for nuclear imaging are provided by Niowave. | |
| nanovista.ca | 2015 | Toronto, Canada | $2.3M | – | Multimodal visualization agents are developed for image-guided interventions. | |
| gfpharma.com | 2012 | Lincoln, United States | – | – | Proprietary chemistry for pharmaceutical synthesis is developed by the company. | |
| cellbion.co.kr | 2010 | Seoul, South Korea | – | – | Radioisotope probes for medical imaging diagnostics are manufactured. | |
| azisotopes.org | 2017 | Bunker Hill, United States | $58.33M | – | Radiopharmaceuticals for diagnostic imaging are developed and produced. | |
| vnir.life | 2017 | Bengaluru, India | $724,462 | – | Infrared fluorescence-based diagnostic molecules are developed for imaging. |
Detailed competitors of ATOMIC ALCHEMY
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atomic Alchemy
Complete news archive for ATOMIC ALCHEMY
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ATOMIC ALCHEMY
10 companies that operate in the same segment as ATOMIC ALCHEMY (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ATOMIC ALCHEMY
ATOMIC ALCHEMY was founded in 2017 and raised its 1st funding round 2 years after it was founded.
ATOMIC ALCHEMY is headquartered in Idaho Falls, United States. It is registered at Idaho Falls, Idaho, United States.
Thomas Eiden is the current CEO of ATOMIC ALCHEMY. They have also founded this company.
ATOMIC ALCHEMY is a funded company, having raised a total of $150K across 1 funding round to date. The company's 1st funding round was a Seed of $150K, raised on Jun 2019.
ATOMIC ALCHEMY, backed by 150000.0 from Y Combinator, focuses on life sciences, life sciences platforms and tools, research reagents and kits, and radioisotopes. Limited information available. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
ATOMIC ALCHEMY's top competitors include ARTMS, NorthStar Medical Radioisotopes and Niowave.
ATOMIC ALCHEMY offers VIPR® Reactor and Fuel Recycling Process.
ATOMIC ALCHEMY has 2 investors. Key investors include Oklo, and Y Combinator.
ATOMIC ALCHEMY operates through Atomic Alchemy Inc.
Yes. ATOMIC ALCHEMY was acquired by Oklo in February 2025.